Polmacoxib

CAS No. 301692-76-2

Polmacoxib ( CG-100649 )

Catalog No. M13942 CAS No. 301692-76-2

Polmacoxib (CG-100649) is a novel NSAID proposed to inhibit both COX-2 and carbonic anhydrase (CA)-I/-II.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 Get Quote
5MG 58 Get Quote
10MG 98 Get Quote
25MG 165 Get Quote
50MG 245 Get Quote
100MG 357 Get Quote
200MG 534 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Polmacoxib
  • Note
    Research use only, not for human use.
  • Brief Description
    Polmacoxib (CG-100649) is a novel NSAID proposed to inhibit both COX-2 and carbonic anhydrase (CA)-I/-II.
  • Description
    Polmacoxib (CG-100649) is a novel NSAID proposed to inhibit both COX-2 and carbonic anhydrase (CA)-I/-II; inhibits premalignant and malignant colorectal lesions in mouse models, partly through inhibiting tumor cell proliferation; induces the G2/M cell cycle arrest in colon cancer cells, and inhibits the tumor growth in colon cancer xenograft in nude mice. Rheumatoid Arthritis Approved
  • Synonyms
    CG-100649
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    Inflammation/Immunology
  • Indication
    Rheumatoid Arthritis

Chemical Information

  • CAS Number
    301692-76-2
  • Formula Weight
    361.39
  • Molecular Formula
    C12H16FNO4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(C1=CC=C(C(OC2(C)C)=C(C3=CC=CC(F)=C3)C2=O)C=C1)(N)=O
  • Chemical Name
    4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Skarke C, et al. Clin Pharmacol Ther. 2012 Jun;91(6):986-93.
2. Kim SH, et al. Invest New Drugs. 2014 Dec;32(6):1105-1112.
3. Woo JK, et al. Oncol Rep. 2015 Apr;33(4):1947-55.
molnova catalog
related products
  • Bufexamac

    Bufexamac is a COX inhibitor for IFN-α release.

  • Isoxicam

    Isoxicam is a novel and long-acting, non-steroidal anti-inflammatory drugs, used to treat arthritis.

  • Suprofen

    Suprofen is a non-steroidal anti-inflammatory drug (NSAID).